Financial PerformanceThe company has reiterated its full-year guidance and management remains confident in the free cash flow outlook, with no fundamental issues impacting the market demand.
Growth And Market PotentialThe diabetes business is seeing positive year-over-year growth for the first time in several quarters, with a new sales force ramping and better CGM results.
LeadershipSuzanne Foster, with over 25 years of diversified healthcare experience, has been appointed CEO, bringing a fresh perspective and leadership stability.